Skip to main content
Livermore
Livermore
ZHEN

Millennium Management LLC

SEC CIK
0001273087
Latest filing
Aug 14, 2026

CRVS holding history

Corvus Pharmaceuticals, Inc. in every 13F filed by Millennium Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRVS overviewAll 13F holders of CRVSFull Q2 2026 holdings

Shares (Q2 2026)
1,047,985
Value
$15.7M
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of CRVS by Millennium Management LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,047,985$15.7M<0.1%+181,623+21.0%AddedHolders
Q1 2026866,362$12.7M<0.1%+177,592+25.8%AddedHolders
Q4 2025688,770$5.30M<0.1%+688,770NewHolders
Q2 20250$00.0%−1,637,138−100.0%Sold outHolders
Q1 20251,637,138$5.21M<0.1%+1,482,237+956.9%AddedHolders
Q4 2024154,901$828.7K<0.1%−156,387−50.2%ReducedHolders
Q3 2024311,288$1.64M<0.1%+106,690+52.1%AddedHolders
Q2 2024204,598$372.4K<0.1%+181,317+778.8%AddedHolders
Q1 202423,281$41.4K<0.1%−17,554−43.0%ReducedHolders
Q4 202340,835$71.9K<0.1%−67,189−62.2%ReducedHolders
Q3 2023108,024$157.7K<0.1%+108,024NewHolders
Q2 20230$00.0%−2,029,423−100.0%Sold outHolders
Q1 20232,029,423$1.85M<0.1%+129,907+6.8%AddedHolders
Q4 20221,899,516$1.61M<0.1%−365,796−16.1%ReducedHolders
Q3 20222,265,312$1.85M<0.1%−422,631−15.7%ReducedHolders
Q2 20222,687,943$2.66M<0.1%−35,596−1.3%ReducedHolders
Q1 20222,723,539$4.47M<0.1%−196,520−6.7%ReducedHolders
Q4 20212,920,059$7.04M<0.1%+2,331,787+396.4%AddedHolders
Q3 2021588,272$2.85M<0.1%+456,837+347.6%AddedHolders
Q2 2021131,435$351.0K<0.1%+32,339+32.6%AddedHolders
Q1 202199,096$305.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.